| The worst outcomes from infection were reduced by nearly 90 percent among high-risk patients, the company data showed. The Pfizer pill could become available within weeks, a crucial development as many versions of a mainstay of covid treatment, monoclonal antibodies, may not be effective against the omicron variant. | 
No comments:
Post a Comment